Drug Trial Radar · NCT06828848
A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections
Last checked: Nov 20, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
44
Planned (sponsor's estimate)
Start
Feb 18, 2025
Primary completion
Oct 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Menarini GroupIndustry
- Sponsor type
- Industry
- First posted
- Feb 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 0 months, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to assess the pharmacokinetic (PK) and safety and tolerability of Vaborem (fixed combination of meropenem and vaborbactam) in the paediatric population aged from birth to \< 18 years with suspected or confirmed Gram negative infections in need of hospitalisation and intravenous (IV) antibiotic administration. All participants will receive Vaborem IV every 8 hours to treat the suspected or confirmed Gram negative infections for 10 up to 14 days; switch to stepdown oral antibiotic is allowed after a minimum of 3 days of Vaborem. PK sample collection will occur after at least 6 doses administration. Participant's clinical conditions will be monitored during the entire duration of the hospitalization and during scheduled visit/s after the completion of the treatment.
Conditions
- Gram Negative Infections
Interventions
Meropenem plus vaborbactamDrug
Meropenem plus vaborbactam fixed dose combination adjusted by body weight up to 2g/2g
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under the concentration-time curve (AUC) for MeropenemTime frame: Day 3
- Area under the concentration-time curve (AUC) for VaborbactamTime frame: Day 3
- Maximum plasma concentration (Cmax) for MeropenemTime frame: Day 3
- Maximum plasma concentration (Cmax) for VaborbactamTime frame: Day 3
- Clearance (CL) of MeropenemTime frame: Day 3
- Clearance (CL) of VaborbactamTime frame: Day 3
- Half-life (t1/2) of MeropenemTime frame: Day 3
- Half-life (t1/2) of VaborbactamTime frame: Day 3
- Steady-state volume of distribution (Vss) of MeropenemTime frame: Day 3
- Steady-state volume of distribution (Vss) of VaborbactamTime frame: Day 3
Locations
22 sites in 5 countries. Site status is shown where the registry gives one.
Fakultni nemocnice Ostrava
Ostrava, Czechia · Terminated
Faculty Hospital Kralovske Vinohrady, Paediatric Clinic
Prague, Czechia · Terminated
Hôpital mère-enfant - CHU de Nantes
Nantes, France · Recruiting
Nice University Hospital (CHU de Nice)
Nice, France · Recruiting
Hospital Armand Trousseau Clinical Research Site
Paris, France · Terminated
Hôpital Robert Debré
Paris, France · Recruiting
CHRU de Tours Hôpital Clocheville Clinical Research Site
Tours, France · Terminated
Policlinico di Bari
Bari, Italy · Recruiting
Ospedale Sant'Orsola
Bologna, Italy · Recruiting
Giannina Gaslini Institute
Genoa, Italy · Terminated
Azienda Ospedaliero-Universitaria di Parma
Parma, Italy · Recruiting
Ospedale Pediatrico Bambino Gesù
Rome, Italy · Recruiting
Ospedale Regina Margherita
Torino, Italy · Recruiting
Insytut Centrum Zdrowia Matki Polki / Polish Mother´s Memorial Hospital Research Institute (ICZMP)
Lodz, Poland · Terminated
Uniwersyteckie Centrum Kliniczne WUM
Warsaw, Poland · Recruiting
Wojskowy Instytut Medyczny - Państwowy Instytut Badawczy
Warsaw, Poland · Recruiting
Hospital Sant Joan de Deu
Barcelona, Spain · Recruiting
Hospital Universitario Puerta del Mar
Cadiz, Spain · Recruiting
Hospital Dr Josep Trueta
Girona, Spain · Recruiting
Hospital General Universitario Gregorio Marañón
Madrid, Spain · Recruiting
Hospital Regional Universitario de Málaga
Málaga, Spain · Terminated
Hospital Clinico Universitario de Santiago de Compostela
Santiago de Compostela, Spain · Terminated
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.